home / stock / ktta / ktta short
Short Information | Pasithea Therapeutics Corp. (NASDAQ:KTTA)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 19,548 |
Total Actual Volume | 125,715 |
Short Trends | |
---|---|
Cover Days | 18 |
Short Days | 0 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 977 |
Average Short Percentage | 14.63% |
Is there a KTTA Short Squeeze or Breakout about to happen?
See the KTTA Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-05-2024 | $5.18 | $5.075 | $5.18 | $5.0631 | 2,612 | 948 | 36.29% |
07-03-2024 | $5.14 | $5.18 | $5.19 | $5.14 | 923 | 19 | 2.06% |
07-02-2024 | $4.83 | $5.155 | $5.155 | $4.83 | 2,486 | 41 | 1.65% |
07-01-2024 | $5.25 | $5.25 | $5.25 | $5.25 | 836 | 28 | 3.35% |
06-28-2024 | $5.28 | $5.0607 | $5.28 | $5 | 700 | 14 | 2% |
06-27-2024 | $5.24 | $5.26 | $5.26 | $5.23 | 953 | 251 | 26.34% |
06-26-2024 | $4.93 | $5.2654 | $5.2654 | $4.93 | 1,174 | 301 | 25.64% |
06-25-2024 | $4.98 | $5.3 | $5.3 | $4.88 | 4,829 | 415 | 8.59% |
06-24-2024 | $4.8 | $4.97 | $4.97 | $4.7999 | 2,556 | 867 | 33.92% |
06-21-2024 | $4.8799 | $4.74 | $4.8799 | $4.74 | 1,605 | 62 | 3.86% |
06-20-2024 | $5.105 | $4.9023 | $5.1403 | $4.8 | 5,731 | 954 | 16.65% |
06-18-2024 | $5.22 | $5.14 | $5.49 | $5.14 | 2,249 | 813 | 36.15% |
06-17-2024 | $5.31 | $5.11 | $5.38 | $5.1 | 7,570 | 483 | 6.38% |
06-14-2024 | $5.4 | $5.26 | $5.4 | $5.26 | 3,585 | 139 | 3.88% |
06-13-2024 | $5.6 | $5.6993 | $5.6993 | $5.45 | 9,741 | 1,484 | 15.23% |
06-12-2024 | $5.84 | $5.7767 | $5.9499 | $5.4 | 30,691 | 2,521 | 8.21% |
06-11-2024 | $5.79 | $5.57 | $6.4999 | $5.57 | 45,483 | 9,971 | 21.92% |
06-10-2024 | $5.6003 | $5.6003 | $5.6003 | $5.6003 | 868 | 10 | 1.15% |
06-07-2024 | $5.6003 | $5.6001 | $5.6003 | $5.6 | 697 | 154 | 22.09% |
06-06-2024 | $0 | $5.6899 | $0 | $0 | 426 | 73 | 17.14% |
News, Short Squeeze, Breakout and More Instantly...
Pasithea Therapeutics Corp. Company Name:
KTTA Stock Symbol:
NASDAQ Market:
Pasithea Therapeutics Corp. Website:
MIAMI, June 13, 2024 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “Company”), a clinical-stage biotechnology company developing PAS-004, a next-generation macrocyclic MEK inhibitor, for the treatment of neurofibromatosis typ...
-- PAS-004 inhibition of in vitro NRAS cell lines does not plateau in contrast to approved MEK inhibitors -- -- PAS-004 inhibition of in vitro NRAS cell lines is greater than selumetinib and binimetinib and similar to trametinib -- -- PAS-004 shows superior activity versus selumetinib and...